Nutrien (NYSE:NTR) Price Target Raised to $54.00

Nutrien (NYSE:NTRFree Report) had its price objective hoisted by UBS Group from $53.00 to $54.00 in a report issued on Thursday,Benzinga reports. They currently have a neutral rating on the stock.

Other equities research analysts have also issued reports about the company. Raymond James upgraded Nutrien from a “market perform” rating to an “outperform” rating and lifted their price target for the company from $58.00 to $60.00 in a research report on Tuesday, December 3rd. CIBC restated an “outperformer” rating and set a $55.00 target price (down previously from $60.00) on shares of Nutrien in a report on Tuesday, December 10th. Piper Sandler increased their price target on shares of Nutrien from $58.00 to $63.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. Scotiabank boosted their price objective on shares of Nutrien from $59.00 to $60.00 and gave the stock a “sector outperform” rating in a research note on Monday, February 10th. Finally, Barclays reaffirmed an “equal weight” rating and set a $56.00 target price (up previously from $55.00) on shares of Nutrien in a research note on Tuesday, January 21st. One research analyst has rated the stock with a sell rating, six have given a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $59.39.

Get Our Latest Stock Analysis on NTR

Nutrien Stock Down 0.9 %

Shares of NYSE NTR opened at $52.68 on Thursday. The firm has a fifty day simple moving average of $49.41 and a two-hundred day simple moving average of $48.24. Nutrien has a 12 month low of $43.69 and a 12 month high of $60.87. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $25.80 billion, a PE ratio of 38.45, a price-to-earnings-growth ratio of 1.19 and a beta of 0.81.

Nutrien (NYSE:NTRGet Free Report) last released its quarterly earnings results on Wednesday, February 19th. The company reported $0.28 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.09). The company had revenue of $5.08 billion during the quarter, compared to the consensus estimate of $5.09 billion. Nutrien had a return on equity of 6.81% and a net margin of 2.62%. Equities analysts expect that Nutrien will post 3.72 earnings per share for the current year.

Nutrien Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 10th. Investors of record on Monday, March 31st will be given a dividend of $0.545 per share. The ex-dividend date of this dividend is Monday, March 31st. This represents a $2.18 dividend on an annualized basis and a yield of 4.14%. Nutrien’s dividend payout ratio (DPR) is 157.67%.

Institutional Investors Weigh In On Nutrien

Large investors have recently added to or reduced their stakes in the stock. Uncommon Cents Investing LLC grew its holdings in shares of Nutrien by 2.1% in the fourth quarter. Uncommon Cents Investing LLC now owns 11,550 shares of the company’s stock worth $517,000 after acquiring an additional 235 shares during the period. Rhumbline Advisers boosted its position in Nutrien by 3.5% in the fourth quarter. Rhumbline Advisers now owns 7,398 shares of the company’s stock worth $331,000 after purchasing an additional 247 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in shares of Nutrien by 6.5% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 4,309 shares of the company’s stock valued at $207,000 after purchasing an additional 263 shares during the period. FFT Wealth Management LLC increased its position in shares of Nutrien by 0.9% during the 4th quarter. FFT Wealth Management LLC now owns 29,732 shares of the company’s stock valued at $1,330,000 after purchasing an additional 277 shares during the last quarter. Finally, Meixler Investment Management Ltd. lifted its stake in shares of Nutrien by 4.2% in the 3rd quarter. Meixler Investment Management Ltd. now owns 7,159 shares of the company’s stock worth $344,000 after purchasing an additional 288 shares during the period. Institutional investors own 63.10% of the company’s stock.

About Nutrien

(Get Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Further Reading

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.